Cargando…

Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study

AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: S Khouri, Albert, Huang, Grace, Y Huang, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684241/
https://www.ncbi.nlm.nih.gov/pubmed/29151685
http://dx.doi.org/10.5005/jp-journals-10028-1233
_version_ 1783278433890992128
author S Khouri, Albert
Huang, Grace
Y Huang, Linda
author_facet S Khouri, Albert
Huang, Grace
Y Huang, Linda
author_sort S Khouri, Albert
collection PubMed
description AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive trabeculectomies with MMC injection (injection group), and thirty eyes with sponge-applied MMC were as controls (sponge group). Data were collected preoperatively and postoperatively at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Demographic data, applanation intraocular pressure (IOP), best-corrected visual acuity (VA), number of glaucoma medications, postoperative interventions, postoperative complications, and number of visits within 3 months were recorded. In order to stratify data, proportion of eyes achieving >30% IOP reduction from baseline with or without glaucoma medications was calculated and defined as surgical success. RESULTS: Mean IOP reduction at 1 year was significant in both the injection and sponge groups from baseline (46.8 and 37.8% respectively). The injection group had overall lower postoperative IOP and comparable complete treatment success, defined as achieving >30% IOP reduction without glaucoma medications (p = 0.941). The number of postoperative visits within 3 months and the proportion of eyes needing 5-fluorouracil (5-FU) intervention were significantly lower in the injection group (p = 0.03, p = 0.04 respectively). CONCLUSION: Injection of MMC was as safe and effective as sponge application with comparable estimated complete treatment success, less need for visits within 3 months, and 5-FU intervention. CLINICAL SIGNIFICANCE: Surgeons may consider intraopera-tive injection of MMC in appropriate patient cohorts given comparable safety and efficacy and several advantages over traditional sponge application. Further study in a prospective, larger, long-term manner is necessary to assess this modality. How to cite this article: Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study. J Curr Glaucoma Pract 2017;11(3):101-106.
format Online
Article
Text
id pubmed-5684241
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-56842412017-11-17 Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study S Khouri, Albert Huang, Grace Y Huang, Linda J Curr Glaucoma Pract Original Article AIM: To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy. MATERIALS AND METHODS: This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive trabeculectomies with MMC injection (injection group), and thirty eyes with sponge-applied MMC were as controls (sponge group). Data were collected preoperatively and postoperatively at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Demographic data, applanation intraocular pressure (IOP), best-corrected visual acuity (VA), number of glaucoma medications, postoperative interventions, postoperative complications, and number of visits within 3 months were recorded. In order to stratify data, proportion of eyes achieving >30% IOP reduction from baseline with or without glaucoma medications was calculated and defined as surgical success. RESULTS: Mean IOP reduction at 1 year was significant in both the injection and sponge groups from baseline (46.8 and 37.8% respectively). The injection group had overall lower postoperative IOP and comparable complete treatment success, defined as achieving >30% IOP reduction without glaucoma medications (p = 0.941). The number of postoperative visits within 3 months and the proportion of eyes needing 5-fluorouracil (5-FU) intervention were significantly lower in the injection group (p = 0.03, p = 0.04 respectively). CONCLUSION: Injection of MMC was as safe and effective as sponge application with comparable estimated complete treatment success, less need for visits within 3 months, and 5-FU intervention. CLINICAL SIGNIFICANCE: Surgeons may consider intraopera-tive injection of MMC in appropriate patient cohorts given comparable safety and efficacy and several advantages over traditional sponge application. Further study in a prospective, larger, long-term manner is necessary to assess this modality. How to cite this article: Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study. J Curr Glaucoma Pract 2017;11(3):101-106. Jaypee Brothers Medical Publishers 2017 2017-10-27 /pmc/articles/PMC5684241/ /pubmed/29151685 http://dx.doi.org/10.5005/jp-journals-10028-1233 Text en Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Article
S Khouri, Albert
Huang, Grace
Y Huang, Linda
Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title_full Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title_fullStr Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title_full_unstemmed Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title_short Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study
title_sort intraoperative injection vs sponge-applied mitomycin c during trabeculectomy: one-year study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684241/
https://www.ncbi.nlm.nih.gov/pubmed/29151685
http://dx.doi.org/10.5005/jp-journals-10028-1233
work_keys_str_mv AT skhourialbert intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy
AT huanggrace intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy
AT yhuanglinda intraoperativeinjectionvsspongeappliedmitomycincduringtrabeculectomyoneyearstudy